Natural history, screening, and management of rheumatic heart disease
- Bongani Mayosi, MBChB, PhD, FCP(SA)
Bongani Mayosi, MBChB, PhD, FCP(SA)
- Professor and Head of Department of Medicine: Faculty of Health Science
- University of Cape Town
Rheumatic heart disease (RHD) remains a major cause of cardiovascular disease in developing nations, although the prevalence of RHD has declined sharply in industrialized countries during the last century .
This topic will review the epidemiology, natural history, screening, and management of RHD. The epidemiology, pathogenesis, diagnosis, treatment, and prevention of acute rheumatic fever are discussed separately. (See "Acute rheumatic fever: Epidemiology and pathogenesis" and "Acute rheumatic fever: Clinical manifestations and diagnosis" and "Acute rheumatic fever: Treatment and prevention".)
Rheumatic heart disease (RHD) is by far the most important form of acquired heart disease in children and young adults living in developing countries (which are inhabited by 80 percent of the world’s population); RHD accounts for about 15 percent of all patients with heart failure in endemic countries [2,3].
RHD is a disease of poverty . The impact of socioeconomic status is illustrated by a study from Kinshasa where the prevalence based on clinical examination was 22.2 per 1000 among children who lived in slums but only 4 per 1000 among children attending the city schools . The importance of socioeconomic factors is further underscored by the virtual disappearance of RHD in the industrialized countries since the mid-20th century, which started well before the introduction of penicillin. In contrast, RHD is still endemic in Africa, Asia, South America, and developing communities of Australasia [6-8].
Echocardiographic diagnostic criteria have revealed high prevalence rates in developing countries; for example, 21.5 per 1000 in Cambodia, 30.4 per 1000 in Mozambique, 48 per 1000 in Nicaragua, and 62 per 1000 in Kenya, providing an average point prevalence of 40 per 1000 in school-aged children [6,7,9]. The prevalence of RHD is 20 per 1000 among young adults (20 to 35 years) in Nicaragua . Based on these data, it is estimated that there are 62 to 78 million individuals who have RHD worldwide, a disease burden that could potentially result in 1.4 million deaths per year from RHD and its complications .
- WHO Technical Report Series. Rheumatic fever and rheumatic heart disease: Report of a WHO expert panel. Geneva 29 October - 1 November 2001. Geneva: WHO; 2004.
- Bocchi EA, Guimarães G, Tarasoutshi F, et al. Cardiomyopathy, adult valve disease and heart failure in South America. Heart 2009; 95:181.
- Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012; 172:1386.
- Rothenbühler M, O'Sullivan CJ, Stortecky S, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health 2014; 2:e717.
- Longo-Mbenza B, Bayekula M, Ngiyulu R, et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol 1998; 63:287.
- Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357:470.
- Paar JA, Berrios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol 2010; 105:1809.
- Lawrence JG, Carapetis JR, Griffiths K, et al. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 2013; 128:492.
- Anabwani GM, Bonhoeffer P. Prevalence of heart disease in school children in rural Kenya using colour-flow echocardiography. East Afr Med J 1996; 73:215.
- Sliwa K, Carrington M, Mayosi BM, et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 2010; 31:719.
- Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008; 94:1534.
- Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 2005; 112:3584.
- Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268:2069.
- Ferrieri P, Jones Criteria Working Group. Proceedings of the Jones Criteria workshop. Circulation 2002; 106:2521.
- Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol 1989; 63:577.
- Minich LL, Tani LY, Pagotto LT, et al. Doppler echocardiography distinguishes between physiologic and pathologic "silent" mitral regurgitation in patients with rheumatic fever. Clin Cardiol 1997; 20:924.
- Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005; 91:1019.
- BLAND EF, DUCKETT JONES T. Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood. Circulation 1951; 4:836.
- Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015; 36:1115.
- FEINSTEIN AR, WOOD HF, SPAGNUOLO M, et al. RHEUMATIC FEVER IN CHILDREN AND ADOLESCENTS. A LONG-TERM EPIDEMIOLOGIC STUDY OF SUBSEQUENT PROPHYLAXIS, STREPTOCOCCAL INFECTIONS, AND CLINICAL SEQUELAE. VII. CARDIAC CHANGES AND SEQUELAE. Ann Intern Med 1964; 60:SUPPL 5:87.
- Vijayaraghavan G, Cherian G, Krishnaswami S, et al. Rheumatic aortic stenosis in young patients presenting with combined aortic and mitral stenosis. Br Heart J 1977; 39:294.
- Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ 1981; 59:285.
- Chesler, E. Rheumatic Valvular Disease. In: Clinical Cardiology, 5, Springer-Verlag, New York 1993. p.263.
- Mayosi B, Robertson K, Volmink J, et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006; 96:246.
- Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J 2006; 96:241.
- Carapetis JR. Rheumatic heart disease in Asia. Circulation 2008; 118:2748.
- Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever--a systematic review. S Afr Med J 2003; 93:212.
- Zühlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep 2013; 15:343.
- Carapetis JR, Hardy M, Fakakovikaetau T, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med 2008; 5:411.
- Marijon E, Ou P, Celermajer DS, et al. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ 2008; 86:84.
- Marijon E, Celermajer DS, Tafflet M, et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009; 120:663.
- Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol 2012; 9:297.
- Oliveira JM, Antunes MJ. Mitral valve repair: better than replacement. Heart 2006; 92:275.
- Chauvaud S, Fuzellier JF, Berrebi A, et al. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001; 104:I12.
- Kumar AS, Talwar S, Saxena A, et al. Results of mitral valve repair in rheumatic mitral regurgitation. Interact Cardiovasc Thorac Surg 2006; 5:356.
- Antunes MJ. Mitral valvuloplasty, a better alternative. Comparative study between valve reconstruction and replacement for rheumatic mitral valve disease. Eur J Cardiothorac Surg 1990; 4:257.
- Kim JB, Kim HJ, Moon DH, et al. Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement. Eur J Cardiothorac Surg 2010; 37:1039.
- NATURAL HISTORY
- Acute rheumatic fever
- Transition from acute to chronic disease
- Chronic valve disease
- - Stages of disease and relationship to age
- - Mitral stenosis
- - Mitral regurgitation
- - Mixed mitral stenosis/regurgitation
- - Aortic regurgitation
- - Aortic stenosis
- - Tricuspid valve disease
- SCREENING IN ENDEMIC SETTINGS
- Types of screening
- Screening summary
- Minimizing disease progression
- Valve disease
- - Management of mitral regurgitation
- - Management of mitral stenosis
- Atrial fibrillation
- Thromboembolism prevention
- - Management of mixed mitral disease
- - Management of aortic regurgitation
- - Management of aortic stenosis
- - Management of mixed aortic valve disease
- - Management of tricuspid valve disease
- - Pregnancy
- HEALTH MAINTENANCE
- SUMMARY AND RECOMMENDATIONS